posted
APPI (.0053) Announces Board Approval to Change Name to World Health Energy, Inc. to Reflect Focus On Renewable Energy Market Federal and State Government Legislation for Alternative Fuel Producers Incentives Anticipated
NEW YORK, Jan. 24, 2007 (PRIME NEWSWIRE) -- Advanced Plant Pharmaceuticals, Inc. (OTCBB:APPI) announced today the company's board of directors has adopted a resolution to change the corporate name to World Health Energy, Inc., to reflect the company's acquisition of World Health Energy, Inc. and the new business plan to focus on biofuels and renewable energy production and distribution. The company anticipates the name change will be completed within sixty days. A new ticker symbol to reflect the corporate name of World Health Energy, Inc. will be issued after the name change has been approved.
The company believes that the alternative fuel sector has been gaining increasing attention from the Federal Government. As President Bush emphasized in the State of the Union address last night, "It is in our vital interest to diversify America's energy supply -- and the way forward is through technology. We must continue changing the way America generates electric power -- by even greater use of clean coal technology ... solar and wind energy ... and clean, safe nuclear power. We need to press on with battery research for plug-in and hybrid vehicles, and expand the use of clean diesel vehicles and biodiesel fuel..... we must increase the supply of alternative fuels, by setting a mandatory fuels standard to require 35 billion gallons of renewable and alternative fuels in 2017 -- this is nearly five times the current target. At the same time, we need to reform and modernize fuel economy standards for cars the way we did for light trucks -- and conserve up to eight and a half billion more gallons of gasoline by 2017."
World Health Energy, Inc. plans to use cost-effective agricultural products both locally and from around the world to develop natural alternative fuels.
The company plans on utilizing ultrasonic processing, a more effective process to attain the required mixing while generating the necessary energy. Most biodiesel is produced in batch reactors where the energy required is generated by heating and mechanical mixing. Significantly, a biodiesel yield in excess of 99% can be achieved through the use of ultrasonication in a very short time span of less than 5 minutes, as compared to the one hour or more time frame necessary when using conventional batch reactor systems. The company believes that the higher yielding process should provide the company with production cost advantages.
The company continues to work towards the closing on the $1.2 million financing previously announced for the construction of two bio-diesel plants slated for Kentucky and Florida. As previously announced, the first of the two biodiesel plants would be built in Kentucky, and the second plant would be constructed in Florida. The financing is subject to completion of mutually satisfactory definitive agreements, necessary government and regulatory approvals, and other customary conditions of closing.
To be added to Advanced Plant Pharmaceutical's corporate e-mail list for shareholders and interested investors, please send an e-mail to ir*advancedplantpharm.com.
About World Health Energy, Inc. (www.worldhealthenergy.com)
World Health Energy, Inc. is a renewable energy company focused on developing and producing alternative fuels. WHE's proposed biodiesel production plants are designed to produce biodiesel that complies to or exceeds international biodiesel production requirements and standards, including the European standard for Biodiesel EN 14214, as well as ASTM D6751 specifications.
About Advanced Plant Pharmaceuticals, Inc. (http://www.advancedplantpharm.com)
Advanced Plant Pharmaceuticals, Inc. (APPI) has focused on the research and development of whole plant-based nutritionals. The company has a composition-oriented patent for a proprietary process of utilizing whole plants to safely manufacture all-natural nutritional supplements. APPI markets and distributes its line of products including Lo-Chol(tm) worldwide through various sales distribution channels. The company is currently in the initial stages of shifting its business plan to enter the rapidly growing renewable energy market.
"Safe Harbor Statement" Under The Private Securities Litigation Reform Act Of 1995
This press release contains forward-looking statements that involve risks and uncertainties. The statements in this release are forward-looking statements that are made pursuant to safe harbor provision of the Private Securities Litigation Reform Act of 1995. Actual results, events and performance could vary materially from those contemplated by these forward-looking statements. These statements involve known and unknown risks and uncertainties, which may cause Advanced Plant Pharmaceuticals, Inc.'s actual results in future periods to differ materially from results expressed or implied by forward-looking statements. These risks and uncertainties include, among other things, product demand and market competition. You should independently investigate and fully understand all risks before making investment decisions.
CONTACT: Advanced Plant Pharmaceuticals, Inc. Investor Relations: LC Group Rick Lutz (404) 261-1196 ir*advancedplantpharm.com
posted
DKGR (.0065) Dividend Issuance and the Jackpot Placer Permit Process via COMTEX
January 24, 2007
SCOTTSDALE, AZ, Jan 24, 2007 (MARKET WIRE via COMTEX News Network) --
Drake Gold Resources, Inc. (PINKSHEETS: DKGR) would like to make known the present state of affairs in regard to the recent announcement of its subsidiary dividend issuance. After the record date was established it became evident that shares held in escrow and those due for cancellation would dilute the dividend for the average shareholder. Upon further review of the current share structure and plans to cancel shares, Drake is rescinding the originally announced record date of January 3rd, 2007 to be replaced by an updated record date to be announced. Drake anticipates this change will allow more dividend shares to be issued to the common shareholder.
With regard to the Jackpot Placer project, it has become apparent to management that there exists a need to have a more measured expectation of the BLM permit filing and approval process. New standards and additional approval steps have been brought to light as staff changes occur at the BLM office. These changes are also affecting many other companies in the area. Therefore, Drake Gold Resources, Inc. has hired a local area professional geologist to work closely with the BLM, and obtain a clear understanding of all paperwork and filings necessary to acquire a permit for placer operations on the Jackpot property. In addition, this professional will fill out and submit these filings as well as monitor its approval status on a regular basis.
The professional geologist met with the Bureau of Land Management on January 17th to discuss in detail all necessary steps for obtaining the permits. This meeting has yielded the necessary information to enable Drake Gold to obtain approval without further delay. At this time Drake Gold is doing all it can to complete this process but will wait to release timeframes until it is closer to completion.
In this regard, interim CEO Clayton Smith stated that, "Though this temporary delay is very frustrating for management as well as shareholders, we value the BLM's desire to protect natural resources and ensure the well being of the environment. Bringing in a local geologist will grant us the ability to comply with all guidelines and expedite mining operations for the Jackpot Placer Project. We need to keep in mind that making sure we are in compliance insulates us from liabilities down the road."
While we continue the transition to becoming a precious metal producer, important updates on permitting, acquisitions, the OTCBB listing process and further developments will be posted at WWW.DRAKEGOLD.COM. Current and future shareholders are encouraged to submit comments and questions for review and public replies released via the CEO Corner and its eNewsletter, both available on the site.
ABOUT LOCAL GEOLOGIST
The local geologist has over 24 years of experience in the geological sciences, waste management, site characterization, property assessments, design and permitting of remediation systems, soil and groundwater remediation and mining. He has been responsible for managing a professional staff to ensure regulatory compliance, quality assurance and maintenance of project schedule and costs. His project experience includes extensive work in soils and groundwater investigations, site mitigation modeling, site remediation selection and design, and site closure. His registrations include: Professional/Registered Geologist (Arizona and California), Certified Remediation Specialist (Arizona), Certified Professional Geologist (AIPG), Registered Environmental Assessor (California), Environmental Response Manager (EPA Certification).
ABOUT DRAKE GOLD RESOURCES, INC.
Drake Gold Resources, Inc. (PINKSHEETS: DKGR) is an early-stage mining and energy company that focuses on the exploration and production of precious metals and energy, such as petroleum and coal. Drake Gold has acquired the rights to the Jackpot Placer Project (JPP) in a southwestern section of Arizona. Estimated reserves on the JPP are 205,000 oz. Operations to recover gold are planned as soon as possible.
DKGR intends to be a diversified company by operating in the natural resource, petroleum, and alternative energy markets. As a result of ever-increasing scarcity, the market for natural resources is clamoring for diversification and innovative exploration tactics. Potential opportunities for diversification include gold, silver and other minerals in areas such as Arizona, Oregon, Alaska, British Columbia, the Yukon Territories, and other affiliated sections throughout gold districts in Northern Mexico.
This press release contains forward-looking statements involving risks and uncertainties including statements regarding the Company's future performance. Such statements are based on management's current expectations and are subject to certain factors, risks and uncertainties that may cause actual results, events and performance to differ materially from those referred to or implied by such statements. In addition, actual future results may differ materially from those anticipated, depending on a variety of factors which include, but are not limited to, our ability to leverage our technology, manage our growth, protect our intellectual property rights, attract new customers and general economic conditions affecting consumer spending, including uncertainties relating to global political conditions, such as terrorism. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. The Company does not intend to update any of the forward-looking statements after the date of this release to conform these statements to actual results or to changes in its expectations, except as may be required by law.
Clayton Smith, CEO Cell: 1-310-728-9445 Email: Info*DrakeGold.com
Corporate Office Scottsdale, AZ Drake Gold Resources Inc. (DKGR) Office: 480-467-4469 Email: Info*DrakeGold.com
SOURCE: Drake Gold Resources, Inc.
mailto:Info*NovakCapital.com http://www.DrakeGold.com mailto:Info*DrakeGold.com mailto:Info*DrakeGold.com Copyright 2007 Market Wire, All rights reserved.
J_U_ICE
posted
DORB(.425)to Host Conference Call on Thursday, January 25 to Discuss Recently Published orBec(R) Phase 3 Clinical Results 1/24/2007
MIAMI, Jan 24, 2007 (BUSINESS WIRE) -- In the first sentence of the second graph, the U.S. dial-in number was incorrect. That number should read: 888-300-4091.
The corrected release reads:
DOR BIOPHARMA TO HOST CONFERENCE CALL ON THURSDAY, JANUARY 25 TO DISCUSS RECENTLY PUBLISHED ORBEC(R) PHASE 3 CLINICAL RESULTS
DOR BioPharma, Inc. (OTCBB:DORB) (DOR or the Company) announced today that it will host a conference call on Thursday, January 25, 2007 beginning at 11 a.m. Eastern time. Christopher J. Schaber Ph.D., President and Chief Executive Officer and author(s) of the Blood paper will discuss the publication as well as the long-term mortality data. The discussion will include detail on DOR's 129-patient pivotal Phase 3, randomized, double-blinded, placebo-controlled multi-center clinical trial of orBec(R) conducted at 16 leading bone marrow/stem cell transplant centers in the U.S. and France; and long-term survival data from its 60-patient Phase 2, randomized, double-blinded, placebo-controlled clinical trial conducted at the Fred Hutchinson Cancer Research Center.
To participate in the conference call please dial 888-300-4091 from the U.S. or 706-902-0808 from outside the U.S. Listeners also can join the webcast by logging into the Company's website at www.dorbiopharma.com approximately 10 minutes prior to the start of the call.
A replay of the call will be available beginning from 2:00 p.m. ET on January 25, 2007 by dialing 800-642-1687 from the U.S. or 706-645-9291 from outside the U.S., and using passcode 7381435. The replay will be available through January 28, 2007 at 11:59 p.m. ET. In addition, the webcast will remain available on DOR's website for at least 30 days.
About DOR BioPharma, Inc.
DOR BioPharma, Inc. is a biopharmaceutical company developing products to treat life-threatening side effects of cancer treatments and serious gastrointestinal diseases, and vaccines for certain bioterrorism agents. DOR's lead product, orBec(R) (oral beclomethasone dipropionate), is a potent, locally-acting corticosteroid being developed for the treatment of GI GVHD, a common and potentially life-threatening complication of bone marrow transplantation. DOR has filed an NDA with the FDA for the treatment of GI GVHD, and has received an FDA PDUFA date of July 21, 2007. An MAA with the EMEA for orBec(R) has also been filed and validated. orBec(R) may also have application in treating other gastrointestinal disorders characterized by severe inflammation.
Through its Biodefense Division, DOR is developing biomedical countermeasures pursuant to the recently enacted Project BioShield Act of 2004. DOR's biodefense products in development are recombinant subunit vaccines designed to protect against the lethal effects of exposure to ricin toxin and botulinum toxin. The ricin toxin vaccine, RiVax(TM), has been evaluated successfully in a Phase 1 clinical trial in normal volunteers.
For further information regarding DOR BioPharma, please visit the Company's website located at www.dorbiopharma.com.
This press release contains forward-looking statements, within the meaning of Section 21E of the Securities Exchange Act of 1934, that reflect DOR BioPharma, Inc.'s current expectations about its future results, performance, prospects and opportunities, including statements regarding the potential use of orBec(R) for the treatment of gastrointestinal GVHD and the prospects for regulatory filings for orBec(R). Where possible, DOR has tried to identify these forward-looking statements by using words such as "anticipates", "believes", "intends", or similar expressions. These statements are subject to a number of risks, uncertainties and other factors that could cause actual events or results in future periods to differ materially from what is expressed in, or implied by, these statements. DOR cannot assure you that it will be able to successfully develop or commercialize products based on its technology, including orBec(R), particularly in light of the significant uncertainty inherent in developing vaccines against bioterror threats, manufacturing and conducting preclinical and clinical trials of vaccines, and obtaining regulatory approvals, that its technologies will prove to be safe and effective, that its cash expenditures will not exceed projected levels, that it will be able to obtain future financing or funds when needed, that product development and commercialization efforts will not be reduced or discontinued due to difficulties or delays in clinical trials or due to lack of progress or positive results from research and development efforts, that it will be able to successfully obtain any further grants and awards, maintain its existing grants which are subject to performance, enter into any biodefense procurement contracts with the U.S. Government or other countries, that the U.S. Congress may not pass any legislation that would provide additional funding for the Project BioShield program, that it will be able to patent, register or protect its technology from challenge and products from competition or maintain or expand its license agreements with its current licensors, or that its business strategy will be successful. Important factors which may affect the future use of orBec(R) for gastrointestinal GVHD include the risks that: because orBec(R) did not achieve statistical significance in its primary endpoint in the pivotal Phase III clinical study (i.e. a p-value of less than or equal to 0.05), the FDA may not consider orBec(R) approvable based upon existing studies, orBec(R) may not show therapeutic effect or an acceptable safety profile in future clinical trials, if required, or could take a significantly longer time to gain regulatory approval than DOR expects or may never gain approval; DOR is dependent on the expertise, effort, priorities and contractual obligations of third parties in the clinical trials, manufacturing, marketing, sales and distribution of its products; or orBec(R) may not gain market acceptance; and others may develop technologies or products superior to orBec(R). These and other factors are described from time to time in filings with the Securities and Exchange Commission, including, but not limited to, DOR's most recent reports on Form 10-QSB and Form 10-KSB. DOR assumes no obligation to update or revise any forward-looking statements as a result of new information, future events, and changes in circumstances or for any other reason.
SOURCE: DOR BioPharma, Inc.
DOR BioPharma, Inc. Evan Myrianthopoulos Chief Financial Officer 786-425-3848 www.dorbiopharma.com or Investor Contacts: Lippert/Heilshorn & Associates Anne Marie Fields, 212-838-3777 afields*lhai.com Bruce Voss, 310-691-7100 bvoss*lhai.com
Copyright Business Wire 2007
Spartans
posted
PLNI .0004
COMPANY NEWS AND PRESS RELEASES FROM OTHER SOURCES:
Plasticon International, Inc. Increases First Quarter 2006 Revenues by More Than $1.4 Million From the First Quarter of the Previous Year
Plasticon First Quarter 2006 Revenues Increased by 2240%
LEXINGTON, KY, Jan 25, 2007 (MARKET WIRE via COMTEX) -- Plasticon International, Inc. (PINKSHEETS: PLNI) is pleased to announce that the Company has posted their unaudited financial statements for the first quarter of 2006. Plasticon International, Inc. increased their revenues to $1,927,592 during the first quarter of 2006 as compared to $82,370 during the first quarter of 2005. This represents an increase of 2240%. The increase in revenue can be attributed to the acquisition and operations of Semco Distribution, Inc., Ultimate Surfaces, LLC, and Pro Mold, Inc. The gross profit for the three months ended March 31, 2006 was $444,696 as opposed to $79,860 for the quarter ended March 31, 2005. The Company has also settled debt in the amount of $6,864,305 through confidential agreements.
"We are very pleased to provide the financial community and our shareholders with our first quarter 2006 financial statements. We are working on the remainder of our financial statements for the 2006 fiscal year," stated Jim Turek, CEO and President of Plasticon International, Inc.
Plasticon International, Inc. recently announced that their wholly owned subsidiary, SEMCO Manufacturing, Inc., will begin surfacing the concrete embankment on the I-515 Beltway Interchange for the Nevada Department of Transportation. The $241,000 contract calls for the application of SEMCO's proprietary concrete sealants and anti-graffiti coating across a 76,400 square foot span of the interchange.
About Plasticon International, Inc. Plasticon International (www.plasticonintl.com) designs, produces, and distributes high-quality concrete accessories, informational & directional signage and plastic lumber, which are all produced from recycled and recyclable plastics. Plasticon is a leader, an innovator of cutting edge design, engineering, and production of industrial and commercial products. Plasticon is a green company, environmentally friendly, using recycled plastics to produce its line of products.
This press release contains "forward-looking statements." Forward-looking statements are statements concerning plans, objectives, goals, strategies, expectations, intentions, projections, expected profits, developments, future events, or performance, underlying (expressed or implied) assumptions and other statements that are other than historical facts. These forward-looking statements are only predictions. No assurances can be given that such predictions will prove correct. Actual events or results may differ materially. Forward-looking statements should be read in light of the cautionary statements and risks that include, but are not limited to, the risks associated with a small company, our comparatively limited financial resources, and other factors that may adversely impact us. These or other risks could cause actual results to differ materially from the future results indicated or implied in such forward-looking statements. We undertake no obligation to update or revise such statements to reflect events, circumstances, or new information after the date of this press release or to reflect the occurrence of unanticipated or other subsequent events.
To automatically receive instant updates, press releases, and other information on this and other Big Apple Consulting USA companies, please visit http://www.bigappleconsulting.com/compro.php and download your FREE copy of Big Apple ComPro.
BARRIE, ON -- (MARKET WIRE) -- 01/25/07 -- Winning Brands Corporation (PINKSHEETS: WNBD) www.WinningBrands.ca announces that Winning Colours® Multi-Cleaner is being listed immediately by H-I-S Paint Mfg. Co. of Oklahoma City for sale in its stores and distribution through its network. H-I-S Paint manufactures and sells paints and coatings from the heart of Oklahoma to the entire country. Since 1972 H-I-S has grown to over 50 paint product lines covering every aspect of the industry including coatings for governments at the city, state and federal level, homebuilders, apartment complexes, schools, hospitals, churches, office buildings, property management companies, contractors and consumers. H-I-S is a member of the Val-Test Distributor Group. Winning Colours® Multi-Cleaner is being listed as a preferred clean-up solution because of its convenience, environmental responsibility, kindness to skin and versatility.
The listing provides Winning Colours® Multi-Cleaner with an important new warehousing, logistics and sales platform in the heartland of America.
Winning Brands' National Sales Manager Lorne Kelly is impressed with the growing recognition by the industry that Winning Colours® Multi-Cleaner is a good partner to make the painting and clean-up experience much easier. "America's economy is so vibrant because its business people are so forward looking," says Kelly. "It is a pleasure to do business in America and form relationships geared to customer satisfaction," he adds. Winning Brands Corporation CEO Eric Lehner adds that market development is going according to plan. "We look forward to moving beyond our 'Initial Operations' stage and into 'Implementation Phase,' with distributors setting up their retailers through training and sell-through." Lehner predicts that additional U.S. states may come on board soon.
Winning Colours® Multi-Cleaner is an environmentally responsible clean-up solution that has come to the attention of professionals in the Paint and Home Improvement industry because of the product's ability to convert most oil-based and other complex stains into simple clean-up with plain water instead of harsh chemicals. The appeal of Winning Colours® Multi-Cleaner is not just its technical performance but also its kindness to skin -- a feature increasingly important to consumers and retailers.
Winning Brands Corporation manufactures Winning Colours® Multi-Cleaner in Canada using North American materials. The company's mission is to replace hazardous chemicals in widespread use with safer alternatives. The company's product range includes consumer and industrial versions of Winning Colours® Multi-Cleaner as well as Solvent Free Solutions(TM) alternatives to toxic Dry Cleaning solvents and other environmental cleaning solutions.
Winning Colors is a Registered Trademark of Niagara Mist Marketing Ltd. and used under licence. Certain statements in this press release that are not historical facts are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements may be identified by the use of words such as "anticipate," "believe," "expect," "future," "may," "will," "would," "should," "plan," "projected," "intend," and similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of Winning Brands Corporation (the Company) to be materially different from those expressed or implied by such forward-looking statements. The Company's future operating results are dependent upon many factors, including but not limited to the Company's ability to: (i) obtain sufficient capital or a strategic business arrangement to fund its expansion plans; (ii) build the management and human resources and infrastructure necessary to support the growth of its business; and (iii) competitive factors and developments beyond the Company's control. Release Nbr:31
Contact Information: Rhonda Windsor Vice-President Winning Brands Corporation (905) 898-2646 11 Victoria Street, Suite 220A Barrie, Ontario, Canada L4N 6T3 Rhonda*WinningBrands.ca Tel (705) 737-4062 Fax (705) 737-9793 www.WinningBrands.ca
onecentlotto
posted
TGLE -- Titan Global Entertainment, Inc. Com ($0.001)
COMPANY NEWS AND PRESS RELEASES FROM OTHER SOURCES:
Titan Global Announces Ty Herndon's New CD "Right About Now" Shipped Over 20,000 Units in Its First Week
MIAMI, FL, Jan 25, 2007 (MARKET WIRE via COMTEX) -- Titan Pyramid Records, a division of Titan Global Entertainment (PINKSHEETS: TGLE), distributed by Universal Music Group, proudly announces that beginning January 9, 2007, Ty Herndon's newly completed album "Right About Now" was released for retail distribution and during its first week orders for this new release were over 20,000 units. This newly released album debuted at number 21 on the Independent Artist Chart and number 41 on the Country Chart. The single release is being aired on the majority of country radio stations within the US and the album is available in every major retail outlet including, FYE's, Wal-Mart, Target, Best Buy, Juke Box distributors and family owned stores; totaling more than 25,000 outlets of distribution. "Music is my life and my passion -- to be a part of the Titan Global Entertainment family -- a multi-faceted team that understands, appreciates and supports my endeavor -- is a great blessing to me. I am excited about our first week of sales and feel the energy that my team is putting forth. I look forward to a great future with Titan / Pyramid Records," stated Ty Herndon.
Titan Global Entertainment, Inc is a multi-faceted entertainment company that specializes in audio and video digital distribution through its state of the art web portal -- TitanTunes.com, the design, production and sale of four multi-media players (The Omni), traditional record production and marketing through Universal Music Group distribution, television, publishing and artist management. Titan is dedicated to supplying new emerging technologies for music to talented artists of various backgrounds on the worldwide web.
Safe Harbor -- This press release includes forward-looking statements that involve risks and uncertainties, including, but not limited to, product delivery, the management of growth, market acceptance of certain products and other risks. These forward-looking statements are made in reliance on the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. For further information about these factors that could affect Titan Global Entertainment, Inc. future results, please contact the Company directly. Prospective investors are cautioned that forward-looking statements are not guarantees of performance. Actual results may differ materially from management expectations.
Press Contact: Titan Global Entertainment, Inc. 305.893.2007
SOURCE: Titan Global Entertainment, Inc.
Copyright 2007 Market Wire, All rights reserved.
J_U_ICE
posted
CYBL (.029) Delivers Next Generation WatchDog Advanced Security Lighting System to U.S. Air Force
PR Newswire "US Press Releases "
RESEARCH TRIANGLE PARK, N.C., Jan. 25 /PRNewswire-FirstCall/ -- Cyberlux Corporation (OTC Bulletin Board: CYBL) announced today that the Company has completed development of the next generation of its WatchDog Portable Covert Illumination System for the United States Air Force and shipped the next order to the Air Mobility Battlelab.
The Air Mobility Battlelab explores high-payoff concepts, technologies, and tactics to advance the distinctive capabilities of Rapid Global Mobility and Agile Combat Support. The next generation WatchDog advanced solid-state LED security lighting system was developed by Cyberlux in conjunction with the Air Mobility Battlelab for the United States Air Force. Upon completion of the new system capabilities, the WatchDog system was shipped to Fort Dix Air Force Base for use within the USAF Air Mobility Command.
The second generation WatchDog system provides security lighting for an exterior boundary of 600 x 600 feet with either visible light or covert infrared light that is compatible with night-vision goggles (NVGs), more than double the first generation system. It was designed to protect military assets on the ground, such as an airplane, by creating a "lightless" zone around the asset while illuminating the surrounding protection boundary. In covert illumination mode, the system increases the visibility of NVGs by almost 6- fold.
The additional order for the second generation WatchDog system, which costs $15,112 on the GSA contract, was placed by the Air Mobility Battlelab for field deployment within various USAF Commands.
As part of the procurement process, the USAF Air Mobility Battlelab conducted a Best Value Determination / Sole Source study that evaluated the WatchDog system against any other available General Services Administration (GSA) contract-approved product and confirmed that the WatchDog system is one- of-a-kind in its capabilities and the only product that meets or exceeds the Battlelab's portable covert illumination system requirements.
"Cyberlux is a leader in solid-state lighting innovation and the next generation WatchDog solid-state lighting system more than doubles the performance of the first generation system, further exceeding the Air Mobility Battlelab requirements," said Mark Schmidt, president and chief operating officer for Cyberlux. "The development and shipment of the second generation WatchDog system for the USAF is a meaningful milestone for the Company's military business unit."
Cyberlux was one of 26 competing companies to submit proposals to develop a lightweight, portable lighting system for both visible lighting and infrared lighting compatible with night vision goggles. Cyberlux was selected during the USAF competitive review process to develop the Portable Covert Illumination System, which weighs less than 50 pounds, including batteries. The system can easily be carried to remote locations and deployed quickly, and with highly efficient LED technology, the system can provide lighting for several days with a single battery charge.
About Cyberlux Corporation
Cyberlux Corporation (OTC Bulletin Board: CYBL) has created breakthrough LED lighting technology that provides the most energy efficient and cost effective lighting solutions available today for consumer, commercial and military uses. The Aeon products bring the newly developed, virtually heatless light into the home for use in closets, cabinet interiors and under cabinet lighting for kitchen counters. The Military and Homeland Security products deliver unique, covert, and advanced visible lighting capability for threat detection, force and asset protection. Cyberlux uses solid-state semiconductors, trademarked as its diodal(TM) lighting elements, which consume 75% less energy than incandescent lighting elements and perform for over 20 years in contrast to 750 hours for conventional bulbs. For more information, please visit www.cyberlux.com.
Public Relations Contacts: Ronnie Welch and Kelly Cinelli, CWR Partners / 508-222-4802 ronnie*cwrpartners.com / kelly*cwrpartners.com
Investor Contact: Equity Relations, Inc. Richard Brown, 617-314-7379
This news release contains forward-looking statements. Actual results could vary materially from those expected due to a variety of risk factors, including, but not limited to, the Company's ability to raise the capital required in completing the acquisition proposed. The Company's business is subject to significant risks and uncertainties discussed more thoroughly in Cyberlux Corporation's SEC filings, including but not limited to, its report on Form 10-KSB for the year ended December 31, 2005 and its 10-QSB for the quarter ended September 30, 2006. The Company undertakes no obligation to publicly release the result of any revisions to these forward-looking statements, which may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.
SOURCE Cyberlux Corporation
DDA
posted
Michelex, Corp. Hires NY Investment Banking Firm JH Darbie & Co. Inc. to Complete the Purchase of AGPro Soybean Processing and Oil Assets as Well as to Fuel Anticipated Ramp Up in Business via COMTEX
January 25, 2007
MASSENA, N.Y., Jan 25, 2007 (*********wire via COMTEX News Network) --
Michelex Corp. (Pink Sheets:MLXO) ("Michelex" or the "Company"), a plastic manufacturing company with its offices in Utah, and an audio record production group located in New York announced today that it has signed an Exclusive Investment Banking agreement with JH Darbie, located 99 Wall Street New York, to arrange financing for up to $5 million, in order to consummate the purchase of the AGPro soybean crushing and soybean oil refining assets located at Massena, New York in St. Lawrence County. JH Darbie has stated several factors that lend insight toward their confidence in carrying out this raise, geared to enable Michelex to enter the rapidly growing soybean oil refining and processing business.
The soybean market has been bolstered primarily due to recent trans-fat replacement regulations, as well as momentum towards alternative fuel and increased demand for Bio-diesel. St. Lawrence County is an ideal location for operating a Soybean Processing Plant as it provides among the lowest electrical power cost in the country; St Lawrence County has readily available farmland, and enjoys proximity to the country's largest East Coast population. Thomas Gramuglia, Chief Executive Officer of Michelex also commented from its head quarters in Utah; "Sales in our plastics business continue to ramp up nicely now that we have eliminated our debt to Wells Fargo Business Credit. We are also excited about our Plastics' Business Outlook for 2007, and share JH Darbie's enthusiasm for value driven opportunities."
About JH Darbie & Co.
JH Darbie & Co. is a financial services firm specializing in private client services, investment banking, financial advisory, institutional investing, and corporate finance. Their network of over 5000 retail clients and numerous institutional investors in both the U.S. and overseas has placed JH Darbie under management of nearly $500M in assets. JH Darbie has over 30 professionals on staff as well as a network of professional and legal advisors with vast experience in all facets of corporate proceedings. Additionally, JH Darbie has a high tier Internet presence with an online trading platform for retail and institutional clientele.
Safe Harbor: This release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The risks and uncertainties that may affect the operations, performance development and results of the Company's business include but are not limited to fluctuations in financial results, availability and customer acceptance of our products and services, the impact of competitive products, services and pricing, general market trends and conditions, and other risks detailed in the Company's SEC reports.
Michelex Corp. Thomas Gramuglia (315) 769-6616 (C) Copyright 2006 *********wire, Inc. All rights reserved.
jos_tul
posted
Satelinx Announces New PDA Enabled Software
MONTREAL, Jan 25, 2007 (MARKET WIRE via COMTEX) -- Satelinx (PINKSHEETS: SLXI) has completed the final stage in developing a GPS tracking software which will allow the individual user to track a vehicle or person using their own PDA cell phone . PDA sales have tripled in the past two years and make up for more than half of all cell phones on the market. It is our desire to tack in on this 30 billion dollar a year market and make our software a standard on all PDA's. "We have been working diligently to integrate our GPS tracking software with today's highly advanced PDA cell phones. This will allow mobile ease of use to all users in order to better track assets and individuals. In today's mobile world, having the ability to be at any place at anytime to keep a watchful eye on your family and assets, without being confined to a single location to monitor, will greatly improve every aspect of security. Adding to a market that's already saturated with PDA technology, we feel that it will be a simple merge into everyday use and will allow us the opportunity to sell our GPS tracking units on a large scale," stated Sam Grinfeld, Chairman of the Board of Satelinx.
About Satelinx
Satelinx International Inc. provides satellite vehicle tracking units that integrates GSM/GPS/GPRS wireless technologies and the Internet to deliver wireless tracking and location services. Satelinx seeks to be recognized as the world leader in providing safety and security solutions on a global scale in a cost effective manner for vehicle owner, trucking or private vehicle fleet and insurance companies.
FORWARD-LOOKING STATEMENTS: This press release contains forward-looking statements, including forecasts of market growth, future revenue, benefits of the proposed merger, and expectations that the merger will be accretive to Satelinx's results and other matters that involve known and unknown risks, uncertainties and other factors that may cause actual results, levels of activity, performance or achievements to differ materially from results expressed or implied by this press release. Such risk factors include, among others: difficulties encountered in integrating merged businesses; uncertainties as to the timing of the merger; approval of the transaction by the stockholders of the companies; the satisfaction of closing conditions to the transaction, including the receipt of regulatory approvals; whether certain market segments grow as anticipated; the competitive environment in the software industry and competitive responses to the proposed merger; and whether the companies can successfully develop new products and the degree to which these gain market acceptance. Actual results may differ materially from those contained in the forward-looking statements in this press release. Satelinx undertakes no obligation and do not intend to update these forward-looking statements to reflect events or circumstances occurring after this press release.
Contact: Sam Grinfeld 514-332-2523
dinner42
posted
Press Release 1/25/07 -------------------------------------------------------------------------------- NMC, Inc. Provides Update Term Sheet Signed Addressing Remaining Class A Preferred and Related Issues; Shareholders of Record: Note Interim Contact re Shares
HENDERSON, Nev.--(BUSINESS WIRE)--NMC, Inc. (Pink Sheets: NMCX) today announced that a term sheet has been signed on behalf of a principal stockholder of the Company providing for, among other things, the sale back to the Company and immediate cancellation of the remaining 400 million Class A Preferred Shares (“poison pill”) currently outstanding, which potentially would have been converted to 2 billion Common shares. Under the term sheet, which anticipates a definitive agreement addressing all related items, the stockholder has agreed that the remaining 400 million Class A Preferred Shares will be returned to the Company and canceled in exchange for $1.6 million to be added to the Company’s indebtedness to the stockholder. The term sheet also provides that the stockholder will compensate the Company (or forgive debt owed to the stockholder) at the rate of $0.01 per post-conversion common share, or $5 million in the aggregate, for 100 million of the Class A Preferred Shares that were previously converted into 500 million shares of common stock. The terms of settlement further require the Company to issue to affiliates of the principal stockholder purchase warrants under SEC rule 144 restrictions for a total of 200 million shares at a strike price of $0.01.
The principal stockholder has pledged total cooperation toward accomplishing all that is in the best interest of the Company and its shareholders. The agreement also addresses various related issues, including additional payment to the Company and/or netting against debt for any other shares that may have been issued without authorization; completion of an audit of the outstanding shares; the calling of a shareholders’ meeting as soon as practicable; releases by the Company in favor of the stockholder and affiliated parties; and related issues.
"I have been very appreciative and impressed with those shareholders who have taken an active role assisting the Company. Their extraordinary efforts, along with those of the NMC board of directors and the principal stockholder, have resulted in an expected agreement designed to allow us to focus on our business plan and set a definitive course for the Company’s future,” said Michael Sheppard, chief executive officer. “Once our share audit is complete, we look forward to presenting our recommendations to NMC shareholders for ratification. We want to assure our shareholders that their trust is paramount and that their votes will be counted,” Sheppard said.
The Company continues to audit original issuances and transfers of Common shares, and management expects to inform shareholders of any adjustments to its previously reported preliminary findings once its audit has been completed.
NMC has selected an independent transfer agent. However, pending the completion of a certified shareholder list following the share audit, the transfer agent is temporarily not in a position to process any transactions in the Company’s stock held in certificate form. In the interim, shareholders of record whose stock is held in certificate form are encouraged to contact the following with their updated mailing address, certificate number(s), and number of shares held. Due to anticipated volume, email or fax is preferable.
Madeleine Franco (madfranco*aol.com) Jordan Richard Assoc. LLC 8183 Mosaic Harbor Avenue Las Vegas, NV 89117 702-256-4905; fax 702-256-4910 Friday, December 22, 2006, as previously announced, the Company received a payment in the amount of $350,000 pursuant to an agreement for the sale of first-stage precious metals ore concentrates for a total purchase price of $500 million to a privately held entity. The December 22 payment is in addition to payments totaling $720,860 made by the buyer during 2003. Clarifying information reported in a Company news release issued on December 27, 2006, payments under the agreement subsequent to the December 22 payment are due on or before the last day of each succeeding month. Additionally, the agreement provides that the customer is eligible to begin taking prorated possession of the first-stage concentrated ore as payments are made.
This news release is for information purposes only and is neither a solicitation to sell securities nor an offer to buy securities, which solicitation or offer may be made only via prospectus. The registration of the Company under the Securities Exchange Act was revoked in March of 2003. Until the Company has effected a new registration with the SEC, Section 12 under which the Company registration was revoked states: "No member of a national securities exchange, broker, or dealer shall make use of the mails or any means or instrumentality of interstate commerce to effect any transaction in, or to induce the purchase or sale of, any security the registration of which has been and is suspended or revoked pursuant to the preceding sentence."
Statements contained in this release that are not purely historical are intended to be forward-looking statements within the meaning of the Safe Harbor clause of the Private Securities Litigation Reform Act of 1995. These statements are based on information available to the Company as of the date of this news release, and the Company assumes no obligation to update or revise these forward-looking statements. Forward-looking statements are inherently uncertain, and the Company’s actual results may differ from management’s expectations. Risks and uncertainties associated with forward-looking statements include without limitation, risks associated with the Company’s ability to complete an audit and obtain registration of its stock with the SEC in light of the allegations against its prior management; the ability of any customer, including the customer whose payment is reported in this news release, to complete its obligations under any agreements with the Company; the Company’s agreement on the terms of a definitive settlement agreement with the stockholder on a timely basis, or at all; the possibility that regulatory actions against the Company or its prior or former management may hinder the Company’s execution of its business plan and attempts to resolve internal and stock issuance issues; delays in obtaining regulatory approvals; costs associated with processing ore concentrates; fluctuation in precious metals markets; general economic and business conditions; litigation and other factors. All forward-looking statements attributable to the Company or persons acting on its behalf are expressly qualified in their entirety by these cautionary statements. Financial estimates, whenever provided, either by the Company or by third parties, are subject to change and are not intended to be relied upon as predictions of future operating results. NMC, Inc. assumes no obligation to update or disclose revisions to such estimates.
Soylent Green
posted
Eternal Image Completes Tooling Process for Major League Baseball(TM) Licensed Funeral Urns
Friday , January 26, 2007 09:00ET
(.0008)
FARMINGTON HILLS, Mich., Jan 26, 2007 (BUSINESS WIRE) -- Eternal Image, Inc. (OTC:ETIM.PK), a public company engaged in the design, manufacturing and marketing of licensed brand image caskets and urns, today announced that it has completed the tooling process for manufacturing its coming line of Major League Baseball(TM) licensed urns.
"This has been and continues to be a very exciting time as we work toward the launch of a line of products that has created great anticipation in the marketplace," said Clint Mytych, president of Eternal Image (EI). "We have a waiting list of consumers who have called and emailed to make clear they want to purchase urns featuring specific teams, and our distributors are eagerly gearing up to sell the products."
EI will roll out the product line in three waves. The first group of urns will include the reigning World Series Champions, St. Louis Cardinals, as well as the Atlanta Braves, Boston Red Sox, Chicago Cubs, Detroit Tigers, Los Angeles Dodgers, New York Yankees and Philadelphia Phillies. Twelve more teams will be added to the line in late 2007 with the balance of 10 teams added in 2008. The urns will have a suggested retail price of $699.
The company has been signing major distributors, recently announcing agreements covering territories that include Delaware, Illinois, Indiana, Maryland, New England, New York/New Jersey and metro-Philadelphia (PA). Additional distribution agreements are expected shortly.
In addition, EI has begun the design phase for the corresponding line of Major League Baseball(TM) caskets, which it expects to complete by month's end.
About Eternal Image
Eternal Image, founded in 2002, is headquartered in Farmington Hills, MI. The company is the first and only manufacturer and marketer of licensed brand image funerary products. Currently, the company offers urns and caskets that feature licensed images from Major League Baseball(TM), Precious Moments(TM) and the Vatican Library Collection(TM), as well as pet urns featuring the American Kennel Club(TM). For more information about EI, visit www.EternalImage.net or call 1-888-6-CASKET.
J_U_ICE
posted
RXPC (.056) Physician to Pharmacy Gateway: Phase 2 Integration
WILMINGTON, Del.--(BUSINESS WIRE)-- Rx Processing Corporation (OTC:RXPC) delivers a physician to pharmacy gateway integrated to our proprietary system. This directly connects credentialed U.S. physicians allowing access to affordable contracted pharmacies and diagnostic providers.
Rx Processing Corp. captures scripts at the point of service, direct from prescribing physicians. This innovative approach will secure advocates and clients by providing physicians a choice as to which fulfillment network they direct their patients. High priced big pharmacies issue physicians a free solution with a professed funding of 100 million dollars on their behalf. Our proprietary solution integrated with valuable laboratory diagnostics costs us a few hundred thousand dollars.
Peter Fiorillo, CEO, commented, “Physicians are on the health care front line and in concert we deliver affordable solutions to obtaining prescription medications and laboratory diagnostics."
O/S: 61,633,577 Float: 21,744,502 Shareholders: 446 Rx Processing Corp. is an innovator in the distribution of pharmaceutical medications and laboratory diagnostics managed at storefront locations with a direct to consumer delivery business model for under and uninsured clients' health care needs. Our technology platform services the needs of U.S. citizens with our secure RxPC advocacy program, independent pharmacy consultant program, and corporate friendly ordering system for laboratory testing and prescription medications through licensed pharmacies in the United States and CLIA-certified patient service centers. The company provides access to FDA approved brand-name and generic medications, thousands of laboratory diagnostics with access to 4,000+ CLIA-certified patient service centers for specimen collection. Rx Processing Corp. estimates that more than 48 million United States citizens would benefit from these company programs.
Safe Harbor Statement:
All statements other than statements of historical fact included in this press release are "forward-looking statements." The forward-looking statements, including those about the company's future expectations, revenues and earnings, and all other forward-looking statements (i.e. operational results and sales) are subject to assumptions and beliefs based on current information known to the company and factors that are subject to uncertainties, risk and other influences, which are outside the company's control, and may yield results differing materially from those anticipated.
posted
SCMI (.0042)Establishes New Subsidiary -- The Amergence Group
Market Wire "US Press Releases "
PHOENIX, AZ -- (MARKET WIRE) -- 01/26/07 -- SunnComm International, Inc. (PINKSHEETS: SCMI), creator of MediaMax(TM), the most widely used audio CD management and enhancement technology in America, announced today that it has formed a new business subsidiary named The Amergence Group. The new company focuses on the development, nurturing and rapid expansion of selected emerging companies across a wide range of industries and disciplines. The new subsidiary will exist alongside the company's current optical media technology unit called Tranzbyte.
The primary goal of the new business development enterprise is to coordinate services and activities which foster and promote a business environment capable of accelerating the growth of innovative companies. It is anticipated that the businesses will be attracted to Amergence in order to take advantage of resources not generally available to small, growing private companies such as mission-critical capital in addition to legal, accounting, and public relations resources. In exchange, the Company will retain a minority ownership position in the promising new businesses. The Company is currently reviewing comprehensive due diligence packages from a number of potential target companies within diverse industries ranging from medical to legal to entertainment.
Peter Jacobs, president of SunnComm International, relates the new subsidiary's mission statement, "To make capital and expertise available to thriving new and innovative business owners without asking them to risk the loss of control of their company (and their lives), as is possible when utilizing traditional venture capitalist methodologies." Jacobs continued, "Many of these emerging businesses have time-critical and specific objectives that require money and resources beyond the reach of the business owners. We will provide an immediate infusion of cash and also contribute an array of business services, professional advice, and guidance in all aspects and all stages of their early development."
TransByte, the other SunnComm subsidiary, will continue to work closely with MediaMax Technology (OTCBB: MMXT) to forge new inroads for its optical media (CD/DVD) technology throughout the entertainment industry. Currently, plans are ongoing to consolidate the various optical media assets of both companies, including SunnComm's current and future optical media products along with its related development and support infrastructure, existing trademarks, intellectual property, and current products under development. Announcements regarding this consolidation are expected to be made shortly.
ABOUT SUNNCOMM
SunnComm International Inc. (PINKSHEETS: SCMI) was the undisputed leader in digital content enhancement and security technology for audio optical media. MediaMax technology has appeared on Gold, Platinum, and Double-Platinum selling albums and on many other best-selling albums, totaling over 165 commercially released CD titles across more than 30 record labels. The company understands and has weathered the challenges surrounding digital content management and enhancement and has recently announced its first introduction of a non-copy protection consumer-enabling product, DVCD(TM). In January 2003 SunnComm co-developed and implemented an early version of the Microsoft Windows Media Data Session Toolkit: (www.microsoft.com/presspass/press/2003/jan03/01-20SessionToolkitPR.asp). For more information about the company, its people and its vision, please visit the Web site at (www.sunncomm.com).
The names of actual companies and products mentioned herein may be the trademarks of their respective owners.
Statements contained in this release, which are not historical facts, may be considered "forward-looking statements" under the Private Securities Litigation Reform Act of 1995. Forward-looking statements are based on current expectations and the current economic environment. We caution the reader that such forward-looking statements are not guarantees of future performance. Unknown risk, uncertainties as well as other uncontrollable or unknown factors could cause actual results to materially differ from the results, performance or expectations expressed or implied by such forward-looking statements.
ABOUT MEDIAMAX TECHNOLOGY
MediaMax Technology Corporation (OTCBB: MMXT), with its international reach and ever-expanding consumer entertainment and lifestyle industry contacts, has been in the enviable position of being privy to industry insider news, trends and developments, thus guiding the team in its strategic growth of new and existing products and services. This positioning further facilitates market penetration of the existing products while setting the stage within the global entertainment industry for future vertical and lateral market infiltration. For additional information about the company, please visit the Company's Web site at (www.mediamaxtechnology.com).
For more information contact: Company contact: Peter H. Jacobs 602-267-7500 peter*sunncomm.com
posted
TMXO (.179) Trimax and Subsidiaries PLC / MSI Sends Delegation Team to Pakistan and South Asia to Launch Initiatives
Market Wire "US Press Releases "
TORONTO -- (MARKET WIRE) -- 01/26/07 -- Trimax Corporation (OTCBB: TMXO) and its wholly owned subsidiaries, Multi-Source Inc. (MSI) and PLC Network Solutions Inc. (PLC), providers of Broadband over Power Line (BPL) communication technologies, announces that they have deployed a team of representatives which includes Trimax President, Derek Pepler, to South Asia, namely Pakistan, and India.
The visit by Trimax is part of a much bigger visit by senior Canadian political delegates which includes Ontario Premier Dalton McQuinty, Dr. Shafiq Qaadri, Parliamentary Assistant to the Minister of Health Promotion, Harinder Takhar, Minister, Ministry of Small and Medium Business, Peter Wilkinson, Chief of Staff to Premier McGuinty and Leslie Marchant, ADM International relations and Chief, and High Commissioner of Canada in Islamabad David Collins.
Trimax and subsidiaries PLC Network Solutions (PLC) and Multi-Source Inc. (MSI) are included as part of various Canadian company delegates to assist in breaking down barriers within the region, and to launch its South Asian initiatives. Trimax believes that South Asia, primarily Pakistan and India, will eventually represent a big part of its overall future growth prospects. Rashid Hasan, senior vice-president of South Asian operations for Trimax, has been instrumental in breaking down barriers within the regions' various governments particularly Pakistan.
Trimax is scheduled to have meetings with various senior Pakistani government officials within the next week to 10 days. The company intends on incorporating Trimax Pakistan, and to have an office facility open within the next 30 to 45 days. The company has further aspirations such as initiating a public listing on the Karachi Stock Exchange within the same period of time depending on regulations. The Karachi Stock Exchange is the biggest and ket capitalization of Rs. 3,257.062 billion (USD $ 54.28 billion) having listed capital of Rs. 486.489 billion (USD $ 8.11 billion). As measured by the KSE 100 Index (http://en.wikipedia.org/wiki/KSE_100_Index), the Karachi stock market has grown rapidly in the current century. The Karachi Stock Exchange was acclaimed as the best-performing stock market of the world in 2002, and is still one of the strongest performers to date. Karachi (http://en.wikipedia.org/wiki/Karachi) is the financial capital of Pakistan. It accounts for the lion's share of Pakistan's GDP and generates about 65% percent of the national revenue providing a Gross Metropolitan Product of $263 billion and a GMP per capita of $21,917 rivaling Western European and American cities. Pakistan's economy is presently growing at fast rate and the country has over the past few years implemented investment friendly policies, which Trimax intends on capitalizing on. The company intends on being the first company within Pakistan that can implement Broadband over Power line technology, and policies.
Trimax and its wholly owned subsidiaries Multi-Source Inc. and PLC Networks Inc. are providers of Broadband over Power Line (BPL) communication technologies. Trimax/MSI/PLC specializes in the development, distribution, implementation, and servicing technologies that use the power grid to deliver 128-bit encrypted high-speed symmetrical broadband for data, voice and video transmission. BPL is a disruptive communications technology that turns the existing ubiquitous power line infrastructure and common electrical wiring in commercial and residential buildings into a high-bandwidth network. Broadband is delivered simultaneously on a single platform, to every electrical outlet throughout the home or business. To connect, users simply plug a modem into any electrical outlet, and plug their computer, phone, security camera or IP device into the modem.
Statements included in this release may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements involve a number of risks and uncertainties such as competitive factors, technological development, market demand and the Company's ability to obtain new contracts and accurately estimate net revenues due to variability in size, scope and duration of projects, and internal issues in the sponsoring client. Further information on potential factors that could affect the Company's financial results, can be found in the Company's Annual and Quarterly Filings and in its Reports on Forms 8-K filed with the Securities and Exchange Commission (SEC).
Investor Relations
This press release has been submitted to http://www.TOP10PressReleases.com for investors to vote on and help move into the TOP 10 of the day. Investors can locate the release by using the industry filter or searching by company name and/or stock symbol.
For more information, please visit (http://www.plcnetworksinc.com/) (http://plcnetsolutions.com/)
posted
BTMD (.0078) Orders Up 3,330% on SHBAN Go Anywhere Hand Sanitizer
Market Wire "US Press Releases "
DALLAS, TX -- (MARKET WIRE) -- 01/26/07 -- BioTech Medics, Inc. (PINKSHEETS: BTMD) announced today that their Dallas FDA-compliant manufacturing plant will be processing a second batch of BioTech's SHBAN(TM) GO Anywhere Hand Sanitizer Mist - 3 oz. bottles next week.
"We are excited to be able to place a second order in less than six weeks from our first order. We are getting unsolicited calls from those who have bought the product telling us how wonderful the SHBAN Hand Sanitizer is to use," said Keith Houser, CEO.
SHBAN has been clinically proven to kill the Avian Bird Flu and other viruses upon contact without harming humans, animals and the environment. The clear superiority of SHBAN over other sanitizers is that SHBAN is longer-lasting as it leaves an invisible protective coating on your hands until you rub or wash it off. SHBAN does not evaporate within one minute after application (compared to alcohol-based hand sanitizers). SHBAN is non-toxic (when used as directed), it is non-bleaching and has no toxic odors.
SHBAN is currently being voluntarily used by flight attendants who work for a major airline based out of Dallas, Texas. BioTech Medics developed SHBAN 3 oz. Go Anywhere Hand Sanitizer so that it may pass the TSA carry-on guidelines for airline passengers and be used during travel.
The SHBAN(TM) solution, in previous in vitro and in vivo testing has been evaluated for its antimicrobial properties against S. Aureus, S. Epidermidis, EC. Faecalis, E. Coli and Ps. Aeruginosa. Tests revealed that SHBAN was extremely effective against all species of bacteria that were tested. SHBAN has previously been tested by Baylor Medical Center in Houston, Louisiana State University, UT Houston. SHBAN is protected under US Letters of Patent #4,868,213, #5,514.808, #5,574,050, #5,679,711 5,679 and #5,585,391.
BioTech Medics is a 21st Century Alternative Medicine company. BioTech has Pain Management & Wellness Centers which feature the NeuroLase Therapeutic Medical Laser, FDA cleared to reduce or eliminate muscular, skeletal or arthritic pain without drugs or surgery.
Safe Harbor for Forward-Looking Statements
This press contains forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995 (the "Act"). Such statements are subject to certain risks and uncertainties and actual results could differ materially from those expressed in any of the forward-looking statements.
Contact: BTMD Investor Relations 1-800-200-2458
J_U_ICE
posted
CSWT (.30) Signs LOI With Chaoyang Liaoyang Special Steel Co. Ltd.
Market Wire "US Press Releases "
NEW YORK, NY -- (MARKET WIRE) -- 01/26/07 -- China Software Technology Group Co., Ltd. (OTCBB: CSWT) ("CSWT") (the "Company") has signed a Letter of Intent with American Wenshen Steel Group, Inc. ("AWSG"), a Delaware Corporation, to acquire Chaoyang Liaoyang Special Steel Co. Ltd., a company registered in the People Republic of China, that is a wholly owned subsidiary of AWSG on January 25, 2007.
The closing of the acquisition is contingent on approval from the Board of Directors of CSWT and AWSG along with the satisfactory exchange of due diligence materials between the two parties.
"We believe this reorganization will bring value to our shareholders," stated Mr. Yuanqin Li, CEO of CSWT. "AWSG is a high-tech company which produces high quality moulded and forged steel. The company is also a member company of China Die and Mould Industry Association."
"If the acquisition is consummated, we believe it will enable AWSG to access the U.S. public markets in order to further its development," stated Mr. Yang Kuidong, Chairman and CEO of Chaoyang Liaoyang Special Steel Co., Ltd. "The market demand for specialty steel and moulds has increased dramatically and there is a huge opportunity for the company to expand," added Mr. Yang.
ABOUT China Software Tech, Inc. (OTCBB: CSWT)
The Company is a holding company for Heng Xing Technology Group Development Limited, a British Virgin Islands corporation ("XHT"). XHT's sole asset is 100% of the outstanding shares of Shenzhen Hengtaifeng Technology Co., Ltd., a People's Republic of China-based corporation ("HTC") located in the Hi-tech Industrial Park in the Nanshan District, Shenzhen, China.
HTC is a provider of application software and system integration services in China. HTC develops and produces housing accumulation fund software and credit guarantee management software products. It also develops family planning and property management software and provides related system integration services. HTC entered this market in 1996 and currently has more than 110 customers in over 20 provinces throughout China.
ABOUT Chaoyang Liaoyang Special Steel Co. Ltd. (AWSG)
The company, located in Chaoyang City of Liaoning province, was registered under the law of the Republic of China. Established in October 2003, the company is a manufacturer of steel forged moulds of high-quality and high-affiliated-added-value. The company owns 5 patents in China for manufacturing high quality mould and forging steel.
Certain of the statements made herein constitute forward-looking statements that involve risks and uncertainties. In such instances, actual results could differ materially as a result of a variety of factors including the risks associated with the effect of changing economic conditions at home and abroad, variations in cash flow, reliance on collaborative retail partners, and on new product development, variations in new product and service development, risks associated with rapid technological change, and potential of introduced or undetected flaws and defects in products and services and other risk factors detailed in forms filed with the Securities and Exchange Commission from time to time.
Contact: Press Contact: For China Software Technology Group Peter Zhou 212-232-0120 ext 230
J_U_ICE
posted
AVRO (.19) Signs Agreement with India CRO Apothecaries to Expand Core Oncology Competencies and Global Presence
Business Wire "US Press Releases "
BOSTON--(BUSINESS WIRE)--
Averion International Corp. (OTCBB:AVRO), a clinical research organization (CRO) specializing in oncology, medical devices, dermatology and nephrology, today announced that is has signed a non-exclusive agreement with Apothecaries Ltd. of New Delhi, India, a full-service CRO with a focus on oncology. Under the terms of the agreement, the two companies will jointly market and contract complementary services to biotechnology, pharmaceutical and medical device companies.
"This strategic alliance enhances our global capabilities as an established CRO in the oncology market segment as we gain Apothecaries' substantial experience in conducting well-run oncology clinical trials," said Philip Lavin, PhD, Averion Chief Executive Officer. "We believe the strategic alliance will bring mutual clinical research opportunities to each group."
"Averion and our Millennix Oncology specialty service brand will also obtain access to leading clinical sites in India with competent staffing and access to a significant patient population, further building on our strategy to expand our global oncology development programs," said Gene D. Resnick, MD, Averion Chief Medical Officer.
Apothecaries has conducted a multitude of early- and late-stage trials in indications including breast, head and neck, and cervical cancers. "We are pleased to partner our extensive capabilities in India with Averion and its solid reputation for offering clinical trials that are executed to the highest standard," said Brijesh Regal, M.Pharm, Apothecaries Chief Executive Officer. He added, "With 23 years of experience, Apothecaries has a large pharma and medical device client base that constitutes stable, repeat business. We offer an expert medical staff and conduct quality, cost effective clinical trials."
About Apothecaries Ltd.
Apothecaries Ltd. provides a host of clinical research services including site management, bioanalytical services, data management, pharmaceutical application software, drug regulatory services in India, and medical information and writing services. Apothecaries initiated clinical trials in 1993. The company offers on staff medical doctors, anesthesiologists and a panel of consultants including various therapeutic specialists. Apothecaries' oncology experience includes ongoing and past Phase I-IIIb studies in indications including head and neck cancer, breast cancer, cervical and persistent cervical cancer, Hodgkin's disease and lung cancer.
With India's population of 1.1 billion, Apothecaries has access to a vast resource pool of study volunteers of a wide age range and ailments from various sections of the community; more than 150 medical college hospitals; and a large number of highly trained and English speaking medical, paramedical and data-management professionals. For more information, visit www.apothecaries.net.
About Averion International Corp.
Averion International Corp. is a full service clinical research organization (CRO) that provides clinical research, and regulatory compliance and validation services to the pharmaceutical, biotechnology and medical device/diagnostic industries. The company has a therapeutic focus in oncology, dermatology, nephrology and medical devices. Averion clinical research core competencies are in FDA and product registration support, site selection, project management, medical and site monitoring, data management, biometrics, pharmacovigilance, medical writing, and full clinical trial management services throughout the clinical trials lifecycle. The company has supported 51 FDA approvals to date with no refusals among submissions accepted for filing; in addition, the company has helped achieve approvals for 12 oncology-related products, as well as multiple approvals in medical devices, cardiology and dermatology.
Averion provides oncology-specific clinical research services through its Millennix Oncology branded service line. (http://www.averionintl.com)
Averion IT&E International Division offers global regulatory compliance and validation services throughout the product development lifecycle. The company's team of industry veterans utilizes the latest tools and procedures to help its clients move quickly and effectively from drug development through the FDA approval process. Consulting services include regulatory planning, providing skilled personnel for development operations, enterprise software and training to manage data and ensure FDA compliance and validation of new pharmaceutical manufacturing facilities. (http://www.iteinternational.com)
Averion is headquartered in Southborough, Mass. and has additional office locations in Rye Brook, N.Y San Diego and San Jose, Calif., and Neu Isenburg (Frankfurt), Germany.
Forward-Looking Statement
Included in this release are "forward-looking statements." Statements in this press release that are forward-looking statements are based on current expectations and assumptions that are subject to risks and uncertainties. In some cases, forward-looking statements can be identified by terminology such as "may," "should," "potential," "continue," "expects," "anticipates," "intends," "plans," "believes," "estimates" and similar expressions. Although the Company believes that the expectations reflected in such forward-looking statements are reasonable, it can give no assurance that such expectations reflected in such forward-looking statements will prove to have been correct. The Company's actual results could differ materially from those anticipated in the forward-looking statements. The Company refers you to the cautionary statements and risk factors set forth in the documents it files with the Securities and Exchange Commission, including its most recent 10-KSB. The Company is not under any obligation (and expressly disclaims any obligation) to update or alter its forward-looking statements, whether as a result of new information, future events, or otherwise.
Cal-Bay International, Inc. (OTCBB:CBAY) announces the company has completed the sponsorship agreements for the MB3 racing division for the Daytona ARCA 200 Event, Saturday Feb. 10, 2007.
Cal-Bay's management today confirmed the sponsorship for the event will completely cover all of the related costs associated with the event.
The MB3 Motor Sports Dodge #14 ARCA racecar will be driven by Michael Faulk and will be televised live nationwide on the Speed Channel.
Cal-Bay's MB3 Motor Sports division is located in Mooresville, North Carolina.
FORWARD LOOKING SAFE HARBOR STATEMENT: To the extent that this release discusses any expectations concerning future plans, financial results or performance, such statements are forward-looking within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities and Exchange Act of 1934, as amended, and are subject to substantial risks and uncertainties. Actual results could differ materially from those anticipated in the forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof and reflect only management's belief and expectations based upon presently available information. These statements, and other forward-looking statements, are not guarantees of future performance and involve risks and uncertainties.
The Company assumes no obligation to update any of the forward-looking statements in this release.
IRVINE, Calif., Jan. 26 /PRNewswire-FirstCall/ -- David T. Laurance, President of Eldorado Exploration (Pink Sheets: EDEX) announced today that the company has completed an oil well in the Canyon Reef located in Briscoe County, Texas.
Eldorado Exploration has a carried 6.25% working interest in the well and a 25% interest in over 16,000 acres of leases located in the Palo Duro Basin. The Company has access to an additional 65,000 acres identified by PIP as potentially productive.
Palo Duro Basin Reef highs that have the potential for oil production have been historically difficult to find using standard seismic methods because the surface of each producing area is small enough to miss. The Canyon Reef oil zones may only cover 20 - 60 acres, but are thick enough to have recoverable reserves of an estimated 400,000 to 600,000 BBLS of oil. The Company believes that there are over 300 potential oil wells on the owned and available acreage. Follow up wells will be attempted in 2007.
The Mesa well drilled by Eldorado Exploration in Roosevelt County, New Mexico is waiting for completion due in the 1st Quarter of 2007. The status of the well has been upgraded from possible to probable with 195 Ft of net pay in 3 zones down to 7064 Ft.
Eldorado Exploration, Inc. is an independent oil and gas company that utilizes a process called Passive Induced Polarization 'PIP' to detect electrostatic signals given off of some geological anomalies. In most cases, a positive response indicates a hydrocarbon accumulation and a negative reading is almost always a dry hole. When used with the standard geological tools and methods, the PIP process enhances the odds of success for discovering oil and gas.
Please be advised that statements made herein, other than historical data, constitute forward-looking statements that involve risks and uncertainties that could cause actual results to differ materially from those stated or implied by such forward-looking statements. The potential risks and uncertainties include, among others, potential volatility in the company's stock price, increased competition, customer acceptance of new products and services offered by the company, uncertainty of future revenue and profitability, and fluctuations in its quarterly operating results. Please also be advised that Eldorado Exploration is a non-reporting Pink Sheets company and is not required to be registered with the Securities and Exchange Commission.
For additional information about Eldorado Exploration, please visit www.eldoradoexploration.com or e-mail eldoex*yahoo.com .
posted